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Abstract
The small heat shock protein, human HspB2, also known as Myotonic Dystrophy Kinase Binding Protein (MKBP), specifically
associates with and activates Myotonic Dystrophy Protein Kinase (DMPK), a serine/threonine protein kinase that plays an
important role in maintaining muscle structure and function. The structure and function of HspB2 are not well understood.
We have cloned and expressed the protein in E.coli and purified it to homogeneity. Far-UV circular dichroic spectrum of the
recombinant HspB2 shows a b-sheet structure. Fluorescence spectroscopic studies show that the sole tryptophan residue at
the 130th position is almost completely solvent-exposed. Bis-ANS binding shows that though HspB2 exhibits accessible
hydrophobic surfaces, it is significantly less than that exhibited by another well characterized small HSP, aB-crystallin.
Sedimentation velocity measurements show that the protein exhibits concentration-dependent oligomerization.
Fluorescence resonance energy transfer study shows that HspB2 oligomers exchange subunits. Interestingly, HspB2
exhibits target protein-dependent chaperone-like activity: it exhibits significant chaperone-like activity towards
dithiothreitol (DTT)-induced aggregation of insulin and heat-induced aggregation of alcohol dehydrogenase, but only
partially prevents the heat-induced aggregation of citrate synthase, co-precipitating with the target protein. It also
significantly prevents the ordered amyloid fibril formation of a-synuclein. Thus, our study, for the first time, provides
biophysical characterization on the structural aspects of HspB2, and shows that it exhibits target protein-dependent
chaperone-like activity.
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Introduction
Myotonic Dystrophy Protein Kinase Binding Protein (MKBP)
associates with and activates Myotonic Dystrophy Protein Kinase
(DMPK), a serine/threonine protein kinase that plays an
important role in maintaining muscle structure and function [1].
CTG expansion in the 39-untranslated region of the DMPK gene
results in retention of the transcript in the nucleus, causing
decreased expression of this protein, leading to the pathology of
Myotonic Dystrophy1 (DM1) [2–4]. The selective up-regulation of
MKBP observed in DM patients is believed to be a feedback
mechanism to compensate for the decreased levels of DMPK [1].
The sequence of MKBP was found to be identical to that of
HspB2, a member of the small heat shock protein (sHsp) family.
MKBP/HspB2 gene was found to be closely linked to the aB-
crystallin gene [5].
Earlier studies implicate an important role for HspB2 in cellular
function and pathology. HspB2 was shown to be expressed in the
heart and skeletal muscle [6–8]. During the differentiation of
C2C12 mouse myoblast cell line, the expression of HspB2 occurs
24 hours after initiation of differentiation [9]. Although HspB2 is
shown not to be heat-inducible [6], during development, it was
found to be transiently up-regulated in the neonatal myocardium;
it was shown to partition into the myofibrillar fraction upon heat
shock [10]. It translocates from the cytosolic to the myofibril
fraction of rat heart during ischemic stress [11]. HspB2 is also
known to protect myocardium from ischemia and help in
recovering from ischemic stress during reperfusion. It is important
in ATP turnover in mouse heart [12]. HspB2 is known to be
associated with mitochondria [13]. HspB2 has also been found in
the senile plaques of Alzheimer disease [14]. Though these studies
clearly indicate the importance of HspB2 in various cellular
functions and pathology, its structural and functional aspects have
not yet been addressed. We have cloned and expressed human
HspB2 in E. coli and purified it to homogeneity. Our study for the
first time sheds light on the structural aspects of HspB2 and shows
that it exhibits molecular chaperone property in preventing
amorphous as well as amyloid aggregation of proteins. However,
unlike other mammalian sHsps characterized so far, it exhibits
unique target protein-dependent chaperone activity.
Materials and Methods
Materials
Citrate synthase, insulin, yeast alcohol dehydrogenase and bis-
ANS (bis-8-anilinonaphthalene-1-sulfonic acid) were purchased
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from Sigma (St. Louis, MO, U.S.A.). Phenyl Sepharose 6 fast flow,
Superose 6 HR pre-packed gel filtration column and high
molecular mass gel filtration calibration kit, were obtained from
Amersham Pharmacia (Uppsala, Sweden). DTT was obtained
from Sisco Research Laboratories (Mumbai, India). TRIzolH was
supplied by GibcoBRL (Grand Island, NY, U.S.A). AdvantageH
RT for PCR kit was procured from BD Biosciences (Palo Alto,
CA, U.S.A.). Human skeletal muscle myoblast (HSMM) and
Skeletal muscle growth medium (SKGM TM-2) bullet kit were
purchased from Lonza, Rockland, USA.
Cloning of human HspB2
HSMM were maintained in SKGM TM-2 and induced to
differentiate in low serum medium. Total RNA was isolated from
myotubes using TRIzolH reagent and cDNA synthesized using
AdvantageH RT for PCR kit. Human HSPB2 was amplified using
the forward primer 59 TTA CAT ATG TCG GGC CGC TCA
GTG -39 (NdeI site underlined) and reverse primer 59 CAA AAG
CTT TCA GGG CTC AAC TAT GG -39(HindIII site
underlined). The amplicon thus obtained was cloned into pET21a
expression vector employing the restriction sites in the primers and
the vector. The sequence of the ligated amplicon was verified by
sequencing and was found to be identical to that reported earlier.
Expression and purification of recombinant human
HspB2
The vector carrying human HspB2 sequence was transformed
into E.coli BL21 DE3 strain (Novagen, Madison, WI, U.S.A.). The
cells were cultured in L-B medium at 37uC in an orbital shaker
incubator at 250 rev/min. Expression was induced by the addition
of IPTG to a final concentration of 1 mM. The cells were
harvested 4 hours after induction and stored at 220uC for further
use. The cells were thawed and lysed by sonication in TNE buffer
(50 mM Tris HCl buffer, pH 7.4, 1 mM EDTA and 100 mM
NaCl) containing the protease inhibitor, PMSF (1 mM) and
lysozyme (200 mg/ml).The lysate was centrifuged at 10000 g at
4uC for 30 min and the supernatant was subjected to ammonium
sulfate precipitation. The protein precipitated out at 20%
ammonium sulfate saturation. The precipitate was resolubilized
in TNE buffer and applied directly onto a Phenyl Sepharose 6 Fast
Flow column previously equilibrated with TNE buffer. The
column was washed with three bed volumes of TNE buffer
followed by elution with TNE buffer containing 40% ethylene
glycol. The protein eluted out with 40% ethylene glycol. Ethylene
glycol was removed by extensive dialysis against TNE buffer,
pH 7.4. The protein was stored at 4uC until further use. The
protein thus purified was homogeneous as determined by SDS-
polyacrylamide gel electrophoresis.
CD spectroscopy
CD spectra were recorded using a Jasco J-715 spectropolarim-
eter. Protein concentrations of 0.2 mg/ml (in 20 mM HEPES –
NaOH buffer, pH 7.4) and 1.5 mg/ml (in TNE buffer) were used
for recording far- and near-UV CD spectra in 0.1 and 1 cm path
length cuvettes respectively. Each spectrum was an average of four
accumulations.
Fluorescence studies
All fluorescence studies were carried out on a Hitachi F4500
fluorescence spectrophotometer. A protein concentration of
0.2 mg/ml in TNE buffer was used for recording intrinsic
tryptophan fluorescence. The measurements were made at an
excitation wavelength of 295 nm and the emission spectra
recorded with excitation and emission band passes set to 2.5 nm.
The hydrophobic probe, bis-ANS, was used for studying
exposed hydrophobic sites. The probe was used at a final
concentration of 10 mM and the protein concentration was
0.2 mg/ml (in TNE). The measurements were made at an
excitation wavelength of 390 nm and excitation and emission
band passes were set to 2.5 nm. Bis-ANS titration study was
carried out by sequential addition of bis-ANS to the protein
solution and fluorescence spectra recorded with above mentioned
instrument parameters. The fluorescence intensity was plotted as a
function of bis-ANS concentration. A similar experiment was also
performed with aB-crystallin under identical conditions for
comparison. All spectra were recorded in a corrected spectrum
mode.
Fluorescence quenching studies
Accessibility of tryptophan was analyzed by fluorescence
quenching experiments. Quenching studies were performed using
a Hitachi F4500 fluorescence spectrophotometer with the
excitation wavelength set at 295 nm and fluorescence emission
spectra were scanned from 300 to 400 nm. Fluorescence
quenching titration with KI was performed at room temperature
by sequentially adding aliquots of concentrated KI solution (7 M)
to a 0.2 mg/ml HspB2 solution. Sodium thiosulphate was added
to KI stock solution to prevent I3¯ formation.
The fluorescence quenching data in the presence of KI were
analyzed by fitting to the Stern-Volmer equation:
F0=F~1zKSV.½Q
Where F0 and F are fluorescence intensities in the absence or
presence of KI, respectively, KSV is the Stern-Volmer quenching
constant and Q is the KI concentration. Percentage accessibility of
tryptophan to quencher was calculated using Lehrer plot [15].
Similar studies were also carried out with N-acetyl tryptophana-
mide (NATA), a modified amino acid tryptophan under identical
conditions.
Sedimentation velocity measurements- Sedimentation velocity mea-
surements were performed using an Optima XL-I analytical
ultracentrifuge (Beckman Coulter, Fullerton, CA, USA). Samples
of 0.125, 1 and 3 mg/ml of HspB2 in TNE buffer were subjected
to centrifugation at 40,000 rpm at 20uC. The protein boundary
was scanned at 1 min intervals using interference optics. The
sedimentation coefficient S20,w and molecular mass of the protein
was calculated using the program SEDFIT [16] which uses non-
linear regression fitting of the sedimenting boundary profile with
Lamm equation,
dc
dt
~
1
r
 d
dr
rD
dc
dr
{sv2r2c
 
which describes the concentration distribution c(r, t) of a species
with sedimentation coefficient s and diffusion coefficient D in a
sector-shaped volume and in the centrifugal field v2r.
Chaperone-like Activity
The chaperone-like activity of HspB2 was assayed by monitor-
ing the DTT-induced aggregation of insulin in 10 mM phosphate
buffer (pH 7.2) containing 100 mM NaCl at 37uC either in the
absence or in the presence of HSPB2. Buffer containing HSPB2 at
different concentrations was incubated at 37uC for 5 min before
addition of insulin to a final concentration of 0.2 mg/ml with
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constant stirring in a cuvette. Temperature was maintained at
37uC using a Julabo thermostatic water bath. The actual
temperature in the cuvette was determined using a Physitemp
microthermocouple thermometer system. Aggregation of insulin
was initiated by adding 24 ml of 1 M DTT to a final assay volume
of 1.2 ml. The extent of aggregation was monitored by measuring
the light scattering at 90u in a Hitachi F4000 fluorescence
spectrophotometer with both excitation and emission wavelengths
set to 465 nm and band passes set to 3 nm.
Thermal aggregation of citrate synthase was carried out in
40 mM HEPES-KOH buffer (pH-7.5) at 43uC. The buffer
containing different concentrations of HspB2 was incubated at
43uC for 8 min before the addition of citrate synthase to a final
concentration of 25 mg/ml in an assay volume of 1.2 ml.
Aggregation was monitored by light scattering as described above.
The thermal aggregation of yeast alcohol dehydrogenase in
50 mM phosphate buffer, pH 7.5, containing 100 mM NaCl was
carried out at 48uC. Buffer containing the indicated concentra-
tions of HspB2 was incubated at 48uC for 8 min before the
addition of yeast alcohol dehydrogenase to a final concentration of
0.2 mg/ml. Aggregation was initiated by the addition of 2 mM
EDTA. Aggregation was monitored by measuring light scattering
as described above.
Subunit exchange studies using fluorescence resonance
energy transfer (FRET)
Subunit exchange studies were performed essentially as
described for aA-crystallin earlier [17,18]. The sole cysteine
residue of HspB2 was covalently labeled with the fluorescence
probes 4-acetamido-49-((iodoacetyl)amino)stilbene-2,29-disulfonic
acid (AIAS) and Lucifer Yellow Iodoacetamide (LYI) separately
by incubating the protein (1 mg/ml) in 20 mM HEPES buffer
(pH 7.4) containing 100 mM NaCl with 4 mM of each of the
probes for at least 18 hrs at 37uC. Following incubation, the
labeled protein was separated from unreacted probes by passing
the solution through a desalting column (PD10) equilibrated with
20 mM HEPES buffer (pH 7.4) containing 100 mM NaCl.
Percentage labeling for each of the probes was estimated by
molar absorption coefficient of the probes.
Subunit exchange was studied by mixing the AIAS- and LYI-
labeled proteins in equimolar ratios in 20 mM HEPES buffer
(pH 7.4) containing 100 mM NaCl at 4, 20 or 37uC. A small
aliquot (10 ml) was withdrawn at different intervals of time and
diluted to 500 ml with 20 mM HEPES buffer (pH 7.4) containing
100 mM NaCl. Fluorescence spectra were recorded from 350 to
600 nm in Hitachi F-4500 fluorescence spectrophotometer with
the excitation wavelength set at 332 nm. The excitation and
emission band passes were set to 5 nm each.
Amyloid fibril growth of a-synuclein
Monomeric a-synuclein (1 mg/ml) in 20 mM HEPES buffer
(pH 7.0) containing 100 mM NaCl was incubated with 0.15 mM
SDS with vigorous stirring at 37uC overnight. Fibrils of a-
synuclein so obtained were sonicated at amplitude of 20 with
5 second on/off cycle in a Sonics vibracell sonicator. The
sonicated fibril sample was used as seed for initiating seeded
amyloid growth.
To study the effect of HspB2 on the seeded fibril growth of a-
synuclein, the sonicated fibril seed of a-synuclein (10% w/w) was
added to 0.5 mg/ml a-synuclein in the absence or the presence of
various concentrations of HspB2 in 20 mM HEPES buffer
(pH 7.0) containing 100 mM NaCl and 0.15 mM SDS. The
mixture was incubated at 37uC. An aliquot (5 ml) was drawn at
various intervals and diluted to 500 ml in 50 mM glycine-NaOH
buffer (pH 8.8) containing 10 mM ThT. Increase in ThT
fluorescence was monitored in a Hitachi F-4000 Fluorescence
spectrophotometer with the excitation and emission wavelengths
set at 445 and 485 nm respectively. The excitation and emission
band passes were set to 10 nm. Increase in the ThT fluorescence
indicates fibril growth and is proportional to the extent of fibril
formation.
Results
We have cloned MKBP/human HspB2 and expressed it in E.
coli. It was obtained mainly in the soluble fraction (Figure 1).
HspB2 was precipitated out with 20% saturated (NH4)2SO4. By a
simple, one-step method of hydrophobic interaction chromatog-
raphy, we could purify HspB2 in good yields and high
homogeneity (Figure 1).
We studied the secondary structure of HspB2 by far-UV
Circular Dichroism (CD) spectroscopy. The far-UV CD spectrum
of HspB2 exhibits a minimum at ,215 nm (Figure 2(a)) and
represents characteristic features indicating that the protein has
significant b-sheet structural elements. Analysis of the CD
spectrum using the CDNN program shows that the protein
contains 3.4% helix, 50.5% b-sheet and 53.9% random coil.
The tertiary structure of HspB2 was investigated by near-UV
CD spectroscopy. Figure 2(b) shows that the near-UV CD
spectrum of HspB2 exhibits chirality in the region between 250–
280 nm representing the chiral structure of phenylalanine and
tyrosine residues and at 286 nm representing tryptophan residue,
indicating a compact tertiary structure of HspB2. We further
probed the tertiary structural aspects around its single tryptophan
residue (at the 130th position) by fluorescence spectroscopy. The
intrinsic tryptophan fluorescence spectrum of HspB2 shows an
emission maximum at 348 nm (Figure 3(a)), indicating that the
sole tryptophan residue of HspB2 is exposed to the solvent. We
have measured the accessibility of the tryptophan residue by
fluorescence quenching by KI (Figure 3(b)). From the Lehrer plot
[15] shown in Figure 3(b), the fractional accessibility of the Trp
Figure 1. SDS-PAGE pattern showing purification of HspB2
from the soluble fraction of E.coli BL21(DE3) cells over-
expressing human HspB2. Lane 1, whole cell lysate; Lane 2, soluble
fraction; Lane 3, insoluble fraction; respectively, Lane 4, HspB2
precipitated by 20% saturated ammonium sulfate; and Lane 5, HspB2
purified by Phenyl Sepharose chromatography.
doi:10.1371/journal.pone.0029810.g001
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residue obtained was 0.8, indicating that the tryptophan residue is
highly accessible to the quencher.
In order to understand the quaternary structure of HspB2, we
have performed sedimentation velocity experiment using an-
alytical ultracentrifugation (Figure 4). Analysis of the sedimenta-
tion profile of the protein at 0.125 mg/ml using the program
SEDFIT shows three populations of HspB2 with S20,w values of
3.6, 5.2 and 6.5 S (figure 4A) corresponding to molecular masses of
,56, 97 and 134 kDa, obtained from fitting the profiles to
Lamm’s equation (See Materials and Methods). However, when
the experiment was performed at higher protein concentrations of
1 and 3 mg/ml the profile changed significantly. At a concentra-
tion of 1 mg/ml, the 56 kDa peak decreased and a significantly
larger peak corresponding to 101 kDa was observed in addition to
peaks corresponding to 149 and 205 kDa. Similarly at 3 mg/ml
peaks corresponding to molecular masses of 114, 192 and 297 kDa
were observed. (figure 4B&C). As the sample preparation of
different protein concentration involved dilution from the stock of
higher concentration of the protein, it appears that the different
species reported by the sedimentation experiments may be in
equilibrium. Thus, the sedimentation velocity measurement shows
that HspB2 exhibits polydisperse populations of multimeric
species. Interestingly, oligomer sizes and the relative concentra-
tions of the species were concentration-dependent.
We have investigated the hydrophobic surfaces on HspB2 using
the hydrophobic probe, bis-ANS. Upon binding to the hydropho-
bic surface of a protein, the fluorescence intensity of bis-ANS is
known to increase several-fold, accompanied by a blue shift in its
emission maximum [19]. Figure 5(a) shows that upon binding to
HspB2 the fluorescence intensity of bis-ANS increases significantly
accompanied by a shift in the emission maximum to ,505 nm,
indicating that HspB2 exhibits accessible hydrophobic surfaces.
Since hydrophobic interactions are important for molecular
chaperone-like activity [20–22], we have compared its bis-ANS
binding property with that of a known molecular chaperone, aB-
crystallin. The extent of binding of bis-ANS to HspB2 is
significantly less compared to that in the case of aB-crystallin
(Figure 5(b)). In addition, it is also seen that while aB-crystallin
exhibits saturable bis-ANS binding, HspB2 binding to bis-ANS
does not seem to be saturable (the fluorescence intensity gradually
increases without saturation behavior even up to the bis-ANS
concentration of 200 mM (data not shown)). The reason for this
unsaturable binding of bis-ANS to HspB2 is not clear. The
observed lack of saturation in bis-ANS binding to HspB2 could be
due to bis-ANS-binding-induced changes in the conformation as
observed in the case of binding of ANS to carbonic anhydrase
[23]. However, the data in the presence of lower concentrations of
bis-ANS (2–10 mM) suggests that HspB2 has much lesser exposed
hydrophobic surfaces than aB-crystallin.
We have investigated whether HspB2 oligomers exhibit
dynamic subunit exchange property. Subunit exchange has been
studied in aA-crystallin by fluorescence resonance energy transfer
Figure 2. Far-UV (a) and near-UV (b) CD spectra of HspB2. Solid
line, human HspB2; dotted line, aB-crystallin. The far- and near-UV CD
spectra of the proteins, were recorded using 0.1 cm and 1.0 cm path
length cuvettes respectively. [h]MRW is mean residue ellipticity.
doi:10.1371/journal.pone.0029810.g002
Figure 3. (a) Intrinsic fluorescence spectrum of HspB2. The excitation
wavelength was 295 nm. The excitation and the emission band passes
were set at 2.5 nm. The concentration of the proteins was 0.2 mg/ml.
Fluorescence intensity is represented in arbitrary units. (b) Lehrer plot of
tryptophan fluorescence quenching of HspB2 by KI. Fluorescence was
monitored after sequential addition of KI to a solution containing
0.2 mg/ml HspB2. Insert shows the decrease in fluorescence intensity
upon sequential addition of KI.
doi:10.1371/journal.pone.0029810.g003
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using AIAS-labeled aA-crystallin as a donor and LYI-labeled aA-
crystallin as an acceptor [17]. HspB2 has a sole cysteine residue at
the 118th position in its sequence. We have labeled the cysteine
residue of HspB2 by AIAS and LYI and studied whether the
labeled protein exhibits FRET upon mixing. Figure 6a shows a
decrease in the fluorescence intensity of AIAS with some increase
in the fluorescence intensity of LYI upon incubating the mixture of
AIAS- and LYI-labeled HspB2 at 37uC for 15 min. This result
indicates a FRET between the fluorophores and hence the subunit
exchange process between the AIAS- and LYI-HspB2 oligomers.
Figure 6b shows the fluorescence spectrum of the mixture of
AIAS- and LYI-labelled HspB2 incubated at 4uC. The spectrum
exhibits the fluorescence spectral characteristics only of AIAS
without any change with respect to incubation time, indicating
that HspB2 does not exhibit subunit exchange at 4uC. However,
we have compared the subunit exchange process of HspB2 at
37uC and 20uC as a function of time and found that the subunit
exchange kinetics are not significantly different at these two
temperatures (Figure 6(c)). Thus, our study shows that HspB2
exhibits the property of subunit exchange among its oligomeric
species.
We have investigated whether HspB2 exhibits chaperone-like
activity towards amorphous aggregation of various target proteins.
Upon reduction of the disulfide bonds, the B-chain of insulin
aggregates [24], leading to increase in light scattering (Figure 7(a)).
In the presence of HspB2, the aggregation of insulin decreased as a
function of HspB2 concentration (Figure 7(a), indicating that it
exhibits chaperone-like activity against the DTT-induced aggre-
gation of insulin. At insulin to HspB2 ratio of 1:0.125 (w/w),
HspB2 exhibited ,37% prevention of aggregation, which
increased to ,71% at insulin to HspB2 ratio of 1: 0.25. With
further increase in HspB2, the extent of protection remained at
,72.5% (Figure 7(b)).
We have also performed the chaperone assay of HspB2 using
thermal aggregation of citrate synthase at 43uC as a model system
(Figure 8(a)-(c)). Surprisingly, unlike in the case of insulin, HspB2
did not exhibit concentration-dependent increase in prevention of
aggregation of citrate synthase. At a citrate synthase to HspB2
Figure 4. Sedimentation velocity profile of HspB2. Distribution of
sedimentation coefficient of different oligomeric species changes with
increasing concentration of HspB2. Panels A, B and C correspond to
0.125, 1 and 3 mg/ml of HSPB2. The numbers depicted above the peaks
correspond to molecular masses (in kDa) of the oligomeric species.
doi:10.1371/journal.pone.0029810.g004
Figure 5. Bis-ANS binding to HspB2. (a) Fluorescence spectra of
bis-ANS alone (dotted line) and bis-ANS bound to human HspB2 (solid
line). Bis-ANS was added to the final concentration of 10 mM and the
spectra were recorded using an excitation wavelength of 390 nm with
the excitation and emission band passes set at 2.5 nm. (b) Bis-ANS
titration of human HspB2. Bis-ANS fluorescence was measured as
described above after sequential additions of bis-ANS to the protein
solutions. (-N-) aB-crystallin, (-m-) HspB2.
doi:10.1371/journal.pone.0029810.g005
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ratio of 1: 0.25 (w/w), the light scattering decreased partially,
indicating partial protection by HspB2. However, as the
concentration of HspB2 increased, there was a gradual but slight
increase in light scattering, indicating that percent protection
decreased with increase in HspB2 concentration (Figure 8(a & b)).
Even at a citrate synthase to HspB2 ratio of 1:8 (w/w), the percent
protection decreased (data not shown). When the assay samples
were centrifuged to separate the soluble protein and precipitate
and the samples analyzed on SDS-PAGE, the amount of HspB2 in
the precipitate increased with increase in HspB2 concentration,
showing that HspB2 co-precipitated with citrate synthase
(Figure 8(c)). Thus, it appears that HspB2 is unable to effectively
prevent the aggregation of citrate synthase, whereas it prevents the
aggregation of insulin to the extent of ,75%. It is possible that
HspB2 is active at 37uC, the temperature at which the insulin
aggregation assay was carried out, whereas it is ineffective at the
elevated assay temperature of 43uC, the assay temperature for
citrate synthase aggregation; hence the lack of activity against
citrate synthase. We have, therefore, investigated the chaperone-
like activity of HspB2 towards the aggregation of yeast alcohol
dehydrogenase (ADH) at 48uC.
Figure 8(d)–(f) shows the effect of HspB2 on the aggregation of
ADH. At an ADH to HspB2 ratio of 1:0.1 (w/w), HspB2 shows
,12.5% protection(curve 2, fig. 8(e)). As the concentration of
HspB2 is increased, it shows a progressive increase in the
chaperone-like activity and at an ADH to HspB2 ratio of 1:2
(w/w), it shows ,83% prevention of aggregation (curve 5,
figure 8(e)). The samples of ADH heated at 48uC in the absence
or the presence of various concentrations of HspB2 in the
chaperone assay described above were centrifuged to separate the
soluble protein and the precipitate. These samples were then run
on SDS-PAGE. It is evident from Figure 8(f) that while almost all
the ADH was obtained in the precipitate in the absence of HspB2,
the amount of ADH recovered in the soluble fraction increased as
the concentration of HspB2 in the assay increased. It is interesting
to note that unlike in the citrate synthase protection assay, very
Figure 6. Subunit exchange studies of HspB2 at different
temperatures. Subunit exchange at (a) 37uC (b) 4uC. The fluorescence
spectra immediately after mixing AIAS and LYI labeled HspB2 in
equimolar ratios (dotted line) and after 15 min (solid line) are
represented. A decrease in AIAS fluorescence intensity with concom-
itant increase in LYI fluorescence intensity indicative of subunit
exchange is seen when the mixture is incubated at 37uC. No such
change was seen at 4uC. The rate of subunit exchange at 37uC (N), 20uC
(m) are compared (c). The rates of subunit exchange at these two
temperatures are similar.
doi:10.1371/journal.pone.0029810.g006
Figure 7. Chaperone-like activity of human HspB2 towards
DTT-induced aggregation of insulin. (a) Aggregation profile of
0.2 mg/ml insulin alone (1); and in the presence of 1:0.0625, (2); 1:0.125,
(3); 1:0.25, (4); and 1:0.5, (5) ratios of insulin to HspB2 (w/w). (b) The
percentage protection of DTT-induced aggregation of insulin by HspB2
as a function of weight ratio of chaperone to target protein.
doi:10.1371/journal.pone.0029810.g007
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little HspB2 was found in the precipitate even at the highest
concentration of HspB2 employed in the assay (fig. 8(f)). Thus,
these studies show that HspB2 can exhibit chaperone-like activity
even at 48uC. HspB2 has the ability to prevent the aggregation of
insulin and ADH, but not that of citrate synthase, indicating that it
exhibits target protein-dependent chaperone-like activity. This
property seems to be different from that of other members of the
mammalian sHsp family such as aA-crystallin, aB-crystallin,
Hsp27 and Hsp22 [25–30].
We have investigated whether HspB2 exhibits chaperone
activity in preventing well-ordered amyloid fibril formation. a-
Synuclein is a natively unstructured presynaptic protein whose
aggregation and amyloid fibril formation is involved in some
neurodegenerative diseases such as Parkinson’s disease, multiple
system atrophy and other synucleinopathies including dementia
with Lewy bodies [31,32]. The anionic detergent SDS, which
mimics membrane environment, has been shown to promote
amyloid fibril formation in vitro [33,34]. We have investigated the
effect of HspB2 on the SDS-induced amyloid fibril formation of a-
synuclein as a model system. Figure 9(a) shows the amyloid fibril
formation of a-synuclein upon seeding with the sonicated
preformed fibril seed as monitored by Thioflavin-T (ThT)
fluorescence. At an a-synuclein to HspB2 ratio of 1:0.5 (w/w),
HspB2 prevents the seeded amyloid fibril growth of a-synuclein to
an extent of ,54%. The extent of prevention of amyloid fibril
formation increases to,63% and to,78% at 1:1 and 1:1.5 (w/w)
ratios respectively of a-synuclein to HspB2 (Figure 9 (b). This
result indicates that HspB2 exhibits chaperone property in
preventing the amyloid fibril formation of a-synuclein.
Interestingly, HspB2 which is predominantly present in the
cytosol of cells translocates to the surface of mitochondria upon
heat stress and protect cells from heat-induced cell death [13]. We
have investigated temperature-induced conformational changes of
HspB2, if any. Figure 10A shows the far-UV CD spectra of HspB2
at 45uC and 55uC. The overall negative ellipticity is increased,
with the increase being more pronounced below 210 nm.
Figure 10B shows the changes in the ellipticity at 214 nm as a
function of temperature. The negative ellipticity gradually
increases till 45uC and increases more sharply above this
temperature. These results indicate that HspB2 does not undergo
global unfolding and loss of its entire secondary structure in the
temperature range studied. However, the increase in negative
Figure 8. Effect of HspB2 on the thermal aggregation of citrate synthase (CS) at 436C. (a) Aggregation profile of 25 mg/ml CS alone (1) and
in the presence of 1:4, (2); 1:2, (3); 1:1, (4) 1:0.5, (5) and 1:0.25, (6) ratios of CS to HspB2 (w/w). (b) The apparent percentage protection calculated from
light scattering profile as a function of the weight ratio of CS to HspB2. (c) The SDS-PAGE pattern of soluble (S) and precipitate (P) fractions of
mixtures of various citrate synthase to HspB2 ratios used in the chaperone assays. The soluble fraction and the precipitate were obtained by
centrifugation at the end of the chaperone assay. (d) Effect of HspB2 on the thermal aggregation of yeast alcohol dehydrogenase (ADH) at 48uC.
Aggregation profile of 0.2 mg/ml ADH alone (1) and in the presence of 1:0.1, (2); 1:0.2 (3); 1:0.5, (4); 1:2 (5); ratios of alcohol dehydrogenase to HspB2
(w/w). (e) the percentage protection calculated from light scattering profile as a function of the weight ratio of ADH to HspB2. (f) SDS-PAGE pattern of
soluble (S) and precipitate (P) fractions of mixtures of various ADH to HspB2 ratios used in the chaperone assays. The soluble fraction and the
precipitate were obtained by centrifugation at the end of the chaperone assay.
doi:10.1371/journal.pone.0029810.g008
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ellipticity which is more pronounced below 210 nm indicates a
significant conformational alteration involving some local unfold-
ing of its secondary structural elements.
Figure 10 C shows that the near-UV CD spectra of HspB2 at
25uC and at 45uC differ only marginally and hence marginal
changes in its tertiary structural packing around the aromatic
amino acid residues. The ellipticity at 286 nm as a function of
temperature shows marginal changes till 45uC and then decreases
sharply with further increase in temperature (Figure 10 (d)). We
have labeled the sole cysteine residue at 118 (in the ‘‘a-crystallin
domain’’) with the fluorescent probe AIAS and measured its
fluorescence polarization as a function of temperature (Figure 10
(e)). The polarization value increases gradually till 45uC, and
decreases more sharply above this temperature resulting in the
increased mobility of the probe above 45uC, indicating the
increased flexibility of the region at higher temperature. Thus, all
these results indicate (i) significant (local) conformational change of
HspB2 around the heat shock temperatures (40–45uC) and (ii) that
HspB2 loses its tertiary structure while having significant
secondary structure at higher temperatures (eg. 55uC), suggesting
that HspB2 exhibits a transition to a molten-globule-like state
[35,36].
Having observed temperature-dependent conformational
changes in HspB2, we have investigated the effect of temperature
on its chaperone-like activity towards the aggregation of insulin.
Figure 10 (f) shows that the percentage protection offered by
HspB2 to insulin increases significantly with increase in temper-
ature, indicating that HspB2 exhibits higher chaperoning
efficiency at temperatures relevant to heat shock.
Discussion
MKBP/HspB2 appears to be an important player in regulating
the homeostasis of the kinase, DMPK which has pleotrophic
functions such as skeletal muscle integrity, cardiac muscle
atrioventricular conduction and ion-channel gating to mention a
few [37]. Studies on the isolated hearts from HspB2 knockout mice
have shown an impaired regeneration of ATP and phosphocre-
atine during recovery after ischemia, indicating its central role in
cardiac energetics during ischemia/reperfusion; further knockout
mice that were administered dobutamine (a strong inotropic and
positive chronotropic) stimulus showed that HspB2 allows for a
greater capacity for increased work during acute inotropic
challenge [38]. It has been reported that DMPK co-localizes with
MKBP/HspB2 at the Z-discs of myocardium and also that it
translocates to the myofibrillar fraction upon heat stress [9].
Despite its important role in various functions, the structural and
functional aspects of HspB2 have not been understood well so far.
As mentioned earlier MKBP/HspB2 shares sequence similarity
especially in the ‘‘alpha-crystallin domain’’ with other sHsps such
as Hsp27 and alpha-crystallins. Despite sequence homology in the
‘‘alpha-crystallin domain’’, members of the sHsp family differ both
in length and sequence in the N-terminal domain as well as the C-
terminal extension. The structural as well as functional aspects of
the members could be different. A comprehensive understanding
of such structural and functional differences among sHsps is not
yet been addressed. Our study shows that MKBP/HspB2 exhibits
several differences in structural and chaperone functional aspects
from those of well-characterized Hsp27 and a-crystallins: (i)
Though HspB2 contains significant b-sheet structure like other
sHsps, it differs significantly in quaternary structure. Small heat
shock proteins such as Hsp27, aA- and aB-crystallin are known to
assemble into large oligomeric complexes with average molecular
masses ranging from 400–600 kDa [39,40]. HspB2 forms discreet
sets of multimeric assemblies in a concentration-dependent
manner. (ii) HspB2 exhibits subtle differences in its subunit
exchange at various temperatures compared to a-crystallins.
Fluorescence resonance energy transfer experiments show that
HspB2 does not exhibit subunit exchange at 4uC, but exhibits
comparable subunit exchange at 20 and 37uC. It has been
suggested that the chaperone-like activity is correlated with the
dynamics of subunit exchange [41,42]. a-Crystallins exhibit much
slower rate of subunit exchange at 20uC compared to that at 37uC
[17,43]. A structural transition above 30uC significantly increases
the chaperone-like activity of a-crystallin [20,21]. Similarly,
MjHsp16.5, the small heat shock protein of Methanococcus jannaschii
shows almost no subunit exchange at 37uC but shows tempera-
ture-induced increase in the rate of subunit exchange and increase
in chaperone-like activity at temperatures above 65uC [41]. The
dynamics of subunit exchange occurring at 20uC might be
contributing to the significant chaperone-like activity of HspB2
against the DTT-induced aggregation of insulin at this temper-
ature. Though the subunit exchange of HspB2 at 20uC is
comparable to that at 37uC, subtle temperature-dependent
conformational changes may be responsible for the observed
increase in its chaperone-like activity at higher temperatures. (iii)
Interestingly, unlike Hsp27 or a-crystallins, HspB2 exhibits target
protein-dependent chaperone-like activity. HspB2 exhibits molec-
ular chaperone-like activity towards the DTT-induced aggregation
Figure 9. Prevention of a-synuclein amyloid fibril formation by
HspB2. (a) Amyloid fibril formation of a-synuclein in the absence (-#-)
and in the presence of HspB2 at a-synuclein to HspB2 ratio of 1:1.5 (-N-)
monitored by ThT fluorescence. HspB2 incubated with a-synuclein
seeds (-m-), or HspB2 alone (-D-) showed negligible ThT fluorescence.
(b) Percentage prevention of a-synuclein amyloid fibril growth in the
presence of various concentrations of HspB2. Error bars for 7 sets of
experimental data are shown.
doi:10.1371/journal.pone.0029810.g009
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of insulin or heat-induced aggregation of alcohol dehydrogenase.
However, it only partially prevents the heat-induced aggregation
of citrate synthase, which does not improve with further increase
in HspB2 concentration – in fact it co-precipitates with citrate
synthase.
The extracellular presence of HspB2 has been reported in the
senile plaques of Alzheimer disease and in cerebral amyloid
angiopathy [14]. Our present study shows that HspB2 prevents the
amyloid fibril growth of, a-synuclein which is known to be present
in the plaques along with Ab peptide. Alpha-synuclein and Ab
peptides are known to interact with each other and modulate the
amyloid fibril formation [44]. Fibril fragments/nuclei of these
proteins can seed the fibril formation of each other [45]. Thus, the
present finding of prevention of amyloid fibril formation of alpha-
synuclein by MKBP/HspB2 has physiological significance in
neurodegenerative diseases.
Studies on isolated hearts of HspB2 knockout mice showed
impaired systolic function and were found to be inefficient in
regenerating vital molecules such as ATP and phosphocreatine
during reperfusion after ischemia [12]. Another study revealed
that HspB2 specifically interacts with and activates DMPK, thus
ameliorating, in part, the insufficiency of DMPK molecules, due to
reduced expression. It does not interact with other kinases closely
related with DMPK [1]. Further, HspB2, forms a complex with
HspB3, but not with other sHsps that are abundantly expressed in
myocytes [9]. It appears that functions performed by HspB2 are
unique and cannot be compensated by other sHsps.
There is increasing evidence that sHsps play important roles in
various diversified cellular functions [46–48] and also are
associated with several pathological conditions [49,50]; these
proteins have been proposed to have therapeutic value [51–53]. In
this context, understanding the structural and functional proper-
ties of individual sHsps is important especially to use sHsps as
therapeutic agents or targets. Our study provides the structural
and chaperone functional aspects of MKBP/HspB2 and its
temperature-dependent changes and highlights the differences in
properties from those of other known sHsps. The findings of target
protein-dependent chaperone activity, its ability to inhibit amyloid
Figure 10. Temperature-induced changes in the conformation and chaperone property of HspB2. (A) far UV-CD spectra of HspB2 at 25uC
(1), 45uC (2) and 55uC (3). (B) The change in the mean residue mass ellipticity ([h]MRM) at 214nm as a function of temperature. (C) Near UV-CD spectra
of HspB2 at 25uC (1), 45uC (2) and 55uC (3). (D) The change in the [h]MRM at 286 nm as a function of temperature. (E) The changes in the fluorescence
polarization of AIAS-labelled HspB2 with increasing temperature. (F) % Protection offered by HspB2 to the DTT-induced aggregation of insulin at
different temperatures.
doi:10.1371/journal.pone.0029810.g010
Structural and Chaperone Properties of HspB2
PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e29810
fibril formation of alpha-synuclein and the subtle conformational
changes at physiologically relevant temperatures may prove useful
in understanding the role of HspB2 in normal and disease
conditions.
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